Ingevity Corp NGVT

About Ingevity Corp (NGVT): stock profile, AI score and financials

Ingevity Corp (NGVT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NGVT at 50.1/100 on a composite quality score built from its SEC filings, placing it at rank #1,635 of 2,925 stocks — the bottom half of the AI-ranked universe. NGVT scores in the top quartile across earnings quality (93.2). Areas of concern include revenue growth (5.9) and institutional flow (20.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 44.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Ingevity Corp reports quarterly revenue of $314.1M, net income of $35.3M, an operating margin of 16.1%. Top institutional holders of NGVT by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NGVT trades on the NYSE exchange and files with the SEC under CIK 1653477. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NGVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ingevity Corp directly from SEC EDGAR.

SEC EDGAR: CIK 1653477 →